NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Alyse D Portnoff,
Michael J Massare,
Matthew B. Frieman,
Pedro A. Piedra,
Larry R Ellingsworth,
Posted 19 Aug 2020
bioRxiv DOI: 10.1101/2020.08.18.256578
Posted 19 Aug 2020
There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective efficacy of a SARS-CoV-2 subunit vaccine (NVX-CoV2373) produced from the full-length SARS-CoV-2 spike (S) glycoprotein stabilized in the prefusion conformation. Cynomolgus macaques (Macaca fascicularis) immunized with NVX-CoV2373 and the saponin-based Matrix-M adjuvant induced anti-S antibody that was neutralizing and blocked binding to the human angiotensin-converting enzyme 2 (hACE2) receptor. Following intranasal and intratracheal challenge with SARS-CoV-2, immunized macaques were protected against upper and lower infection and pulmonary disease. These results support ongoing phase 1/2 clinical studies of the safety and immunogenicity of NVX-CoV2327 vaccine ([NCT04368988]). ### Competing Interest Statement Authors MGX, NP, JHT, BZ, SM, KL, ADP, MJM, GG, GS and LE are current or past employees of Novavax Inc. a for-profit organization and these authors own stock or hold stock options. These interests do not alter the authors adherence to policies on sharing data and materials. MBF and PAP declare no competing interests. : /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT04368988&atom=%2Fbiorxiv%2Fearly%2F2020%2F08%2F19%2F2020.08.18.256578.atom
- Downloaded 2,150 times
- Download rankings, all-time:
- Site-wide: 3,688 out of 100,737
- In immunology: 117 out of 3,135
- Year to date:
- Site-wide: 777 out of 100,737
- Since beginning of last month:
- Site-wide: 200 out of 100,737
Downloads over time
Distribution of downloads per paper, site-wide
- 20 Oct 2020: Support for sorting preprints using Twitter activity has been removed, at least temporarily, until a new source of social media activity data becomes available.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!